key: cord-0785441-113jw3tt
authors: Mazzilli, Sara; Oliani, Francesco; Restivo, Andrea; Giuliani, Ruggero; Tavoschi, Lara; Ranieri, Roberto
title: Antigenic rapid test for SARS-CoV2 screening of individuals newly admitted to detention facilities: sensibility in an asymptomatic cohort
date: 2021-05-11
journal: Journal of clinical virology plus
DOI: 10.1016/j.jcvp.2021.100019
sha: 641d24637dfec08f91717ecd19aae77c93c13ceb
doc_id: 785441
cord_uid: 113jw3tt

Background Since the start of the Sars-CoV-2 pandemic, attention was called on the potential risk of COVID-19 outbreaks occurring inside prisons. In detention facilities, timely and accurate diagnosis is essential for allowing case isolation and contact tracing to avoid the spread of the infection. Until recently, reverse-transcriptase polymerase chain reaction (rt-PCR) was the recommended method to diagnose SARS-CoV-2 infection. However, antigen-detecting rapid diagnostic tests (ag-RDT) have emerged as point-of-care testing techniques. Objectives Here, we evaluate the use of ag-RDT for screening of individuals newly admitted to San Vittore prison (SV), a pre-trial prison, in Milan (Lombardy region, Italy), during the second SARS-CoV2 epidemic peak. Methods During the period 1 October-31 December 2020, ag-RDT and rt-PCR were performed individuals newly admitted to SV. Results Among 504 detained individuals tested, 21 (4,2%) resulted positive to rt-PCR. Of these, 10 had tested negative with ag-RDT and 11 had concordant results. Rt-PCR cycle threshold (CT) values were above 35 for the individuals with ag-RDT negative test, therefore the cases missed by the ag-RDT are unlikely to transmit disease. For all the individuals with ag-RDT positive results, CT values were below or equal to 27. In our study population, ag-RDT sensitivity was 52.4% (29.8%-74.3%), positive predictive value (PPV) was 100% and negative predictive value was 98.0% (96.8%-98.7%). Discussion Our study showed that ag-RDT is a promising and useful component of serial testing strategies in prison settings to perform SARS-CoV2 screening at admission based to its high PPV, ease of use, lower costs and resource needs.

diagnose SARS-CoV-2 infection. However, antigen-detecting rapid diagnostic tests (ag-RDT) have emerged as point-of-care testing techniques.

Objectives Here, we evaluate the use of ag-RDT for screening of individuals newly admitted to San Vittore prison (SV), a pre-trial prison, in Milan (Lombardy region, Italy), during the second SARS-CoV2 epidemic peak.

Methods During the period 1 October-31 December 2020, ag-RDT and rt-PCR were performed individuals newly admitted to SV.

Results Among 504 detained individuals tested, 21 (4,2%) resulted positive to rt-PCR. Of these, 10 had tested negative with ag-RDT and 11 had concordant results. Rt-PCR cycle threshold (CT) values were above 35 for the individuals with ag-RDT negative test, therefore the cases missed by the ag-RDT are unlikely to transmit disease. For all the individuals with ag-RDT positive results, CT values were below or equal to 27. In our study population, ag-RDT sensitivity was 52.4% (29.8%-74.3%), positive predictive value (PPV) was 100% and negative predictive value was 98.0% (96.8%-98.7%).

Discussion Our study showed that ag-RDT is a promising and useful component of serial testing strategies in prison settings to perform SARS-CoV2 screening at admission based to its high PPV, ease of use, lower costs and resource needs.

Keywords: antigen-detecting rapid diagnostic tests, Rt-PCR cycle threshold, sensitivity, detention facility.

Since the start of the Sars-CoV-2 pandemic, attention was called on the potential risk of COVID-19 outbreaks occurring inside prisons (1) . Proximity, overcrowding, infrastructural constraints and environmental circumstances pose people in detention (PiD) at higher risk of acquiring infection. The likelihood of COVID-19 introduction in detention facilities is notably high, mainly due to two factors: firstly, turnover of PiD is considerable, especially in pre-trial institutions (2) , and staff working in prison access the premises on daily bases. This risk is even more relevant for those prisons located in areas with sustained community virus circulation. Secondly, individuals in contact with the criminal justice system are usually from socially deprived communities with higher prevalence of communicable and non-communicable diseases and sub-optimal access to care, including to SARS-CoV2 testing facilities (3).

In prison settings, timely and accurate diagnosis is essential for allowing case isolation and contact tracing to avoid the spread of the infection. Until recently, reverse-transcriptase polymerase chain reaction (rt-PCR) was the recommended laboratory method to diagnose SARS-CoV-2 infection.

However, it requires special laboratory equipment, skilled staff, high cost, and turn-around time for results may be extended due to high demand. Antigen-detecting rapid diagnostic tests (ag-RDT) give results in about 15 minutes, are easy to perform and have emerged recently as point-of-care testing techniques (4).

The aim of this study was to evaluate the use of ag-RDT for screening of individuals newly admitted to San Vittore prison (SV), a pre-trial detention facility, in Milan (Lombardy region, Italy), during the second SARS-CoV2 epidemic peak. Contrariwise, for all the individuals with rt-PCR and ag-RDT positive results, rt-PCR CT values were below or equal to 27. In our study population, ag-RDT sensitivity and specificity were respectively 52.4% (95% CI: 29.8%-74.3%) and 100% (95% CI: 99.2%-100%), the positive predictive value (PPV) was 100% and the negative predictive value (NPV) was 98.0% (95% CI: 96.8%-98.7%).

To the best of our knowledge, this is the first study reporting the use of ag-RDT in detention facilities.

Our results showed that, owing to faster turnaround time, ag-RDT can be used profitably as a component of serial testing strategies in prison settings to perform SARS-CoV2 screening at admission.

Furthermore, our study contributes to accumulating evidence describing ag-RDT sensitivity among asymptomatic individuals. Our findings are in line with previously reported estimates (5) .

As previously shown (6), despite lower sensitivity than rt-PCR detecting viral RNA, ag-RDT perform well on individuals with high viral load in their upper respiratory tract, who are also more likely to generate secondary cases. This has direct implications for the use of ag-RDT in prison settings, as these tests have the potential of quickly identifying newly admitted individuals at higher risk for SARS-CoV2 introduction and onward transmission within detention facilities.

In conclusion, our study showed that ag-RDT is a promising and useful component of serial testing strategies in prison settings to perform SARS-CoV2 screening at admission based to its high PPV, ease of use, lower costs and resource needs.

Prevention and Control of COVID-19 in Italian Prisons: Stringent Measures and Unintended Consequences

Prisons and custodial settings are part of a comprehensive response to COVID-19

SPACE I -2019 -Council of Europe Annual Penal Statistics: Prison populations

Centre for Disease Prevention and Control. COVID-19 Testing Strategies and Objectives

Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms

Performance of a rapid antigen test in the diagnosis of SARS-CoV-2 infection